Skip to main content
. 2018 Apr 11;18:407. doi: 10.1186/s12885-018-4224-x

Fig. 8.

Fig. 8

Bexarotene inhibits the viability of A549 cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway. a The expression of slc10a2 and PPARγ in A549 cells treated with 1 mM, 5 mM, 10 mM bexarotene respectively. b The quantification of slc10a2 and PPARγ expression in A549 cells treated with 1 mM, 5 mM, 10 mM bexarotene respectively. c The expression of slc10a2, PTEN, mTOR in A549 cells treated with bexarotene, bexarotene + GW9662 respectively. d The quantification of slc10a2, PTEN, mTOR expression in A549 cells treated with bexarotene, bexarotene + GW9662. All experiments were repeated 3 times. *p < 0.05, **p < 0.01